Clinical Oncology

Overview

Clinical oncology is the branch of medicine devoted to the diagnosis, treatment, and supportive management of cancer in patients. It integrates the assessment of tumor type, stage, and biological behavior with therapeutic modalities including surgery, chemotherapy, radiotherapy, targeted agents, and immunotherapy, alongside symptom control and survivorship care. Effective oncology depends closely on diagnostic pathology, which establishes the diagnosis, characterizes tumor grade and proliferative activity, and informs prognosis and treatment selection. Proliferation indices such as Ki-67, mitotic counts, and immunohistochemical markers like phosphohistone H3 are used to gauge how aggressively a tumor is dividing, as illustrated in the evaluation of invasive breast carcinoma. Molecular and proteomic-genomic techniques increasingly contribute biomarkers that refine classification, predict response, and enable personalized therapy. Clinical oncology also encompasses the management of treatment-related complications, including infections such as invasive aspergillosis in patients with hematological malignancy, and the nutritional and metabolic consequences of cancer, exemplified by interventions targeting cachexia. Research in this field spans biomarker discovery and validation, diagnostic accuracy, supportive care, and the translation of laboratory findings into clinical practice. By linking pathological diagnosis with evidence-based therapy and supportive measures, clinical oncology aims to improve survival, preserve function, and individualize care across the cancer continuum.

Research published in this journal

6 peer-reviewed articles, ranked by relevance. Each links to its DOI.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics